AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol

Laboratory of Biochemical Genetics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Diabetes (Impact Factor: 8.47). 11/2009; 59(3):554-63. DOI: 10.2337/db09-0482
Source: PubMed

ABSTRACT Resveratrol, a natural polyphenolic compound that is found in grapes and red wine, increases metabolic rate, insulin sensitivity, mitochondrial biogenesis, and physical endurance and reduces fat accumulation in mice. Although it is thought that resveratrol targets Sirt1, this is controversial because resveratrol also activates 5' AMP-activated protein kinase (AMPK), which also regulates insulin sensitivity and mitochondrial biogenesis. Here, we use mice deficient in AMPKalpha1 or -alpha2 to determine whether the metabolic effects of resveratrol are mediated by AMPK.
Mice deficient in the catalytic subunit of AMPK (alpha1 or alpha2) and wild-type mice were fed a high-fat diet or high-fat diet supplemented with resveratrol for 13 weeks. Body weight was recorded biweekly and metabolic parameters were measured. We also used mouse embryonic fibroblasts deficient in AMPK to study the role of AMPK in resveratrol-mediated effects in vitro.
Resveratrol increased the metabolic rate and reduced fat mass in wild-type mice but not in AMPKalpha1(-/-) mice. In the absence of either AMPKalpha1 or -alpha2, resveratrol failed to increase insulin sensitivity, glucose tolerance, mitochondrial biogenesis, and physical endurance. Consistent with this, the expression of genes important for mitochondrial biogenesis was not induced by resveratrol in AMPK-deficient mice. In addition, resveratrol increased the NAD-to-NADH ratio in an AMPK-dependent manner, which may explain how resveratrol may activate Sirt1 indirectly.
We conclude that AMPK, which was thought to be an off-target hit of resveratrol, is the central target for the metabolic effects of resveratrol.

Download full-text


Available from: Shutong Yang, Aug 31, 2015
1 Follower
  • Source
    • "Moreover, RESV, per se, is a powerful oxidant that in a moderate to high μM range (N 50 μM) was shown to activate AMPK in a SIRT1-independent manner, improving mitochondrial function and, consequently, neuronal survival [6] (Fig. 1). Likewise, RESV failed to improve metabolic parameters and mitochondrial biogenesis in AMPKα1 subunit KO mice [78], revealing an important role of this kinase regulated under conditions favoring ATP metabolism. Concordantly, high doses of RESV improved neuronal survival in Sir2 homozygous null flies expressing mHtt exon 1 with 93Q (Httex1pQ93) [58]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sirtuins are a conserved family of NAD(+)-dependent class III lysine deacetylases, known to regulate longevity. In mammals, the sirtuin family has seven members (SIRT1-7), which vary in enzymatic activity, subcellular distribution and targets. Pharmacological and genetic modulation of SIRTs has been widely spread as a promising approach to slow aging and neurodegenerative processes. Huntington's disease (HD) is a neurodegenerative disorder linked to expression of polyglutamine-expanded huntingtin (HTT) protein for which there is still no disease-reversing treatment. Studies in different animal models provide convincing evidence that SIRT1 protects both cellular and animal models from mutant HTT toxicity, however controversial results were recently reported. Indeed, as a consequence of a variety of SIRT-activation pathways, either activation or inhibition of a specific SIRT appears to be neuroprotective. Therefore, this review summarizes the recent progress and knowledge in sirtuins (particularly SIRT1-3) and their implications for HD treatment. Copyright © 2015. Published by Elsevier B.V.
    Biochimica et Biophysica Acta 07/2015; DOI:10.1016/j.bbadis.2015.07.003 · 4.66 Impact Factor
  • Source
    • "Earlier reports established that RSV acted through direct activation of SIRT1 (Howitz et al., 2003); however, a more recent study proposed an indirect modulation of SIRT1 via inhibition of cAMP phosphodiesterases (Park et al., 2012). Nevertheless, the preponderance of evidences indicates that RSV activates SIRT1 through direct and indirect actions (Canto et al., 2010; Um et al., 2010) and that the metabolic effects of RSV depend on acute activation of AMPK (Baur et al., 2006) via a SIRT1-independent mechanism (Price et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pre-clinical findings have provided mounting evidence that resveratrol, a dietary polyphenol, may confer health benefits and protect against a variety of medical conditions and age-related complications. However, there is no consistent evidence of an increased protection against metabolic disorders and other ailments when comparing studies in laboratory animals and humans. A number of extraneous and potential confounding variables can affect the outcome of clinical research. To date, most of the studies that have investigated the effect of resveratrol administration on patient outcomes have been limited by their sample sizes. In this review we will survey the latest advances regarding the timing, dosage, formulation, bioavailability, and toxicity of resveratrol, and resveratrol-drug interactions in human studies. Moreover, the present report focuses on the actions of resveratrol treatment in combatting diseases, such as cancer, diabetes, neurodegeneration, cardiovascular disease, and other age-related ailments.
    Ageing research reviews 01/2015; 21. DOI:10.1016/j.arr.2015.01.002 · 7.63 Impact Factor
  • Source
    • "Resveratrol also shows antioxidant properties as it directly scavenges free radicals and promotes the function of enzymatic antioxidants in cells. Resveratrol has also been shown to improve mitochondrial activity and stimulate autophagy through the activation of the AMPK pathways involving PGC-1 [23]–[25]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria form a reticulum network dynamically fuse and divide in the cell. The balance between mitochondria fusion and fission is correlated to the shape, activity and integrity of these pivotal organelles. Resveratrol is a polyphenol antioxidant that can extend life span in yeast and worm. This study examined mitochondria dynamics in replicative senescent yeast cells as well as the effects of resveratrol on mitochondria fusion and fission. Collecting cells by biotin-streptavidin sorting method revealed that majority of the replicative senescent cells bear fragmented mitochondrial network, indicating mitochondria dynamics favors fission. Resveratrol treatment resulted in a reduction in the ratio of senescent yeast cells with fragmented mitochondria. The readjustment of mitochondria dynamics induced by resveratrol likely derives from altered expression profiles of fusion and fission genes. Our results demonstrate that resveratrol serves not only as an antioxidant, but also a compound that can mitigate mitochondria fragmentation in replicative senescent yeast cells.
    PLoS ONE 08/2014; 9(8):e104345. DOI:10.1371/journal.pone.0104345 · 3.23 Impact Factor
Show more